NCT01723553 - Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Atypical Alzheimers DiseaseLogopenic Variant of Primary Progressive Aphasia (LPA)Posterior Cortical Atrophy (PCA)

Interventions

DRUG

C-11 PiB

One time intravenous administration of \~740 megabecquerel (MBq) of \[N-methyl-C-11\]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole (PiB) (range 370 - 740 MBq).

Trial Locations (1)

55905

Mayo Clinic, Rochester